Suchergebnisse - "Ow, Samuel G. W."

PubPharm (16)

1

Phase II study of trifluridine/tipiracil in metastatic breast cancers with or without prior exposure to fluoropyrimidines

enthalten in: European journal of cancer (Oxford, England : 1990) | 2023

von Lim, J. | Ow, S. | Wong, A. | +9

2

Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor-Positive Breast Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von Lim, J. | Wong, A. | Ow, S. | +20

3

Serial Tumor Molecular Profiling of Newly Diagnosed HER2-Negative Breast Cancers During Chemotherapy in Combination with Angiogenesis Inhibitors

enthalten in: Targeted oncology | 2022

von Choo, J. | Jan, Y. | Ow, S. | +17

4

Serial Tumor Molecular Profiling of Newly Diagnosed HER2-Negative Breast Cancers During Chemotherapy in Combination with Angiogenesis Inhibitors

enthalten in: Targeted oncology | 2022

von Choo, J. | Jan, Y. | Ow, S. | +17

5

Serial Tumor Molecular Profiling of Newly Diagnosed HER2-Negative Breast Cancers During Chemotherapy in Combination with Angiogenesis Inhibitors

enthalten in: Targeted oncology | 2022

von Choo, J. | Jan, Y. | Ow, S. | +17

6

A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours

enthalten in: BMC cancer | 2020

von Ang, Y. | Ho, G. | Soo, R. | +11

7

A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours

enthalten in: BMC cancer | 2020

von Ang, Y. | Ho, G. | Soo, R. | +11

8

A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours

enthalten in: BMC cancer | 2020

von Ang, Y. | Ho, G. | Soo, R. | +11

9

Nurse-Led Vital Signs Monitoring Can Safely Identify Low-Risk Hematology-Oncology Patients For De-Escalation

enthalten in: JCO oncology practice | 2020

von Tham, S. | Kasinathan, S. | Lui, P. | +4

10

Phase I Trial of Expanded, Activated Autologous NK-cell Infusions with Trastuzumab in Patients with HER2-positive Cancers

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2020

von Lee, S. | Shimasaki, N. | Lim, J. | +20